%0 Journal Article
%T Tau oligomers in cerebrospinal fluid in Alzheimer's disease
%A Diana Castillo©\Carranza
%A Douglas Galasko
%A Erik Portelius
%A Henrik Zetterberg
%A Kaj Blennow
%A Kathleen Farmer
%A Oskar Hansson
%A Randall Woltjer
%A Urmi Sengupta
%J Archive of "Annals of Clinical and Translational Neurology".
%D 2017
%R 10.1002/acn3.382
%X With an increasing incidence of Alzheimer's disease (AD) and neurodegenerative tauopathies, there is an urgent need to develop reliable biomarkers for the diagnosis and monitoring of the disease, such as the recently discovered toxic tau oligomers. Here, we aimed to demonstrate the presence of tau oligomers in the cerebrospinal fluid (CSF) of patients with cognitive deficits, and to determine whether tau oligomers could serve as a potential biomarker for AD
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376754/